| Application no. and date | 06825836.7 (espacenet) (Federated) (European Patent Register), 20061012 | | Patent/reg. no. and date | DK/EP 1948620, 20130320 | | Publication date | 20080730 | | Priority no. and date | US 726290 P, 20051013 | | EP pub. no. and date |
EP 1948620 20080730 | | Effective date | | | Applicant/owner | Aventis Pharmaceuticals Inc., 300 Somerset Corporate Boulevard
Bridgewater, New Jersey 08807-0800, US | | Applicant ref. no. | AVENTIS US2005/090 | | Inventor | SHERER, Daniel, 4 Hampton Drive
Berkley Heights, New Jersey 07922, US,
LANGEVIN, Beverly, 220 Bald Eagle Drive
Stewartsville, New Jersey 08886, US,
ORTON, Edward, 88 Briarwood Drive East
Berkley Heights, New Jersey 07922, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , C07D 239/46 (2006.01) , C07D 239/47 (2006.01) | | Title | Dihydrogenphosphatsalt af en prostaglandin-2D-receptorantagonist | | Int. application no. | US2006039901 | | Int. publication no. | WO2007047378 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
